Impact of Telemonitoring for the Management of Side Effects in Patients with Melanoma, Lung or Renal Cancer, Treated with Immunotherapy Combination of Nivolumab and Ipilimumab or Adjuvant Nivolumab Monotherapy

NCT04605146 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Melanoma
Lung Cancer
Renal Cancer

Interventions

BEHAVIORAL: Tele-monitoring

Sponsor

Hospices Civils de Lyon